My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    Inhibition of secreted phospholipase A2 by neuron survival and anti-inflammatory peptide CHEC-9.

    Cunningham TJ, Maciejewski J, Yao L.

    J Neuroinflammation. 2006 Sep 11;3:25.PMID: 16965626 [PubMed]Related articlesFree article

    2.

    Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties.

    Cunningham TJ, Yao L, Lucena A.

    J Inflamm (Lond). 2008 Oct 22;5:17.PMID: 18945345 [PubMed - in process]Related articlesFree article

    3.

    Systemic treatment of cerebral cortex lesions in rats with a new secreted phospholipase A2 inhibitor.

    Cunningham TJ, Souayah N, Jameson B, Mitchell J, Yao L.

    J Neurotrauma. 2004 Nov;21(11):1683-91.PMID: 15684658 [PubMed - indexed for MEDLINE]Related articles

    4.

    Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis.

    Cunningham TJ, Yao L, Oetinger M, Cort L, Blankenhorn EP, Greenstein JI.

    J Neuroinflammation. 2006 Sep 11;3:26.PMID: 16965627 [PubMed]Related articlesFree article

    5.
    6.

    Group IIA secretory PLA2 inhibition by ursolic acid: a potent anti-inflammatory molecule.

    Nataraju A, Raghavendra Gowda CD, Rajesh R, Vishwanath BS.

    Curr Top Med Chem. 2007;7(8):801-9.PMID: 17456043 [PubMed - indexed for MEDLINE]Related articles

    7.

    Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis.

    Sato H, Kato R, Isogai Y, Saka G, Ohtsuki M, Taketomi Y, Yamamoto K, Tsutsumi K, Yamada J, Masuda S, Ishikawa Y, Ishii T, Kobayashi T, Ikeda K, Taguchi R, Hatakeyama S, Hara S, Kudo I, Itabe H, Murakami M.

    J Biol Chem. 2008 Nov 28;283(48):33483-97. Epub 2008 Sep 18.PMID: 18801741 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat.

    Hoda MN, Singh I, Singh AK, Khan M.

    J Neuroinflammation. 2009 Aug 13;6:21.PMID: 19678934 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Secretory PLA2 inhibitor indoxam suppresses LDL modification and associated inflammatory responses in TNFalpha-stimulated human endothelial cells.

    Sonoki K, Iwase M, Sasaki N, Ohdo S, Higuchi S, Takata Y, Iida M.

    Br J Pharmacol. 2008 Apr;153(7):1399-408. Epub 2008 Feb 11.PMID: 18264128 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor.

    Rouault M, Le Calvez C, Boilard E, Surrel F, Singer A, Ghomashchi F, Bezzine S, Scarzello S, Bollinger J, Gelb MH, Lambeau G.

    Biochemistry. 2007 Feb 13;46(6):1647-62.PMID: 17279628 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prediction of in vivo drug-drug interactions from in vitro data : factors affecting prototypic drug-drug interactions involving CYP2C9, CYP2D6 and CYP3A4.

    Brown HS, Galetin A, Hallifax D, Houston JB.

    Clin Pharmacokinet. 2006;45(10):1035-50.PMID: 16984215 [PubMed - indexed for MEDLINE]Related articles

    13.

    Alpha-lipoic acid: an inhibitor of secretory phospholipase A2 with anti-inflammatory activity.

    Jameel NM, Shekhar MA, Vishwanath BS.

    Life Sci. 2006 Dec 14;80(2):146-53. Epub 2006 Sep 1.PMID: 17011589 [PubMed - indexed for MEDLINE]Related articles

    14.

    Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.

    Six DA, Barbayianni E, Loukas V, Constantinou-Kokotou V, Hadjipavlou-Litina D, Stephens D, Wong AC, Magrioti V, Moutevelis-Minakakis P, Baker SF, Dennis EA, Kokotos G.

    J Med Chem. 2007 Aug 23;50(17):4222-35. Epub 2007 Aug 2.PMID: 17672443 [PubMed - indexed for MEDLINE]Related articles

    15.

    The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection.

    Tran TA, McCoy MK, Sporn MB, Tansey MG.

    J Neuroinflammation. 2008 May 12;5:14.PMID: 18474101 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Novel peptide inhibitors of human secretory phospholipase A2 with antiinflammatory activity: solution structure and molecular modeling.

    Thwin MM, Satyanarayanajois SD, Nagarajarao LM, Sato K, Arjunan P, Ramapatna SL, Kumar PV, Gopalakrishnakone P.

    J Med Chem. 2007 Nov 29;50(24):5938-50. Epub 2007 Nov 1.PMID: 17973469 [PubMed - indexed for MEDLINE]Related articles

    17.
    18.

    Inhibition of secreted phospholipase A2. 4-glycerol derivatives of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one with broad activities.

    Touaibia M, Djimdé A, Cao F, Boilard E, Bezzine S, Lambeau G, Redeuilh C, Lamouri A, Massicot F, Chau F, Dong CZ, Heymans F.

    J Med Chem. 2007 Apr 5;50(7):1618-26. Epub 2007 Mar 3.PMID: 17335183 [PubMed - indexed for MEDLINE]Related articles

    19.

    In vivo profiling of DPP4 inhibitors reveals alterations in collagen metabolism and accumulation of an amyloid peptide in rat plasma.

    Jost MM, Lamerz J, Tammen H, Menzel C, De Meester I, Lambeir AM, Augustyns K, Scharpé S, Zucht HD, Rose H, Jürgens M, Schulz-Knappe P, Budde P.

    Biochem Pharmacol. 2009 Jan 15;77(2):228-37. Epub 2008 Oct 1.PMID: 18940185 [PubMed - indexed for MEDLINE]Related articles

    20.

    Synthesis and evaluation of benzophenone oximes derivatized with sydnone as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.

    Kamble RR, Belgur SS, Aladkatti R, Khazi IA.

    Chem Pharm Bull (Tokyo). 2009 Jan;57(1):16-21.PMID: 19122311 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk